CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −3,776 | $25.22 | $95K | 9,350 |
| 2025-11-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,455 | $26.02 | $38K | 7,895 |
| 2025-11-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −600 | $27.54 | $17K | 7,295 |
| 2025-11-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −100 | $29.35 | $3K | 7,195 |
| 2025-10-08 | SMITH IAN F Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +570,000 | 570,000 | ||
| 2025-10-08 | SMITH IAN F Chief Executive Officer | Grant or award · Restricted Stock Units | +380,000 | 380,000 | ||
| 2025-10-08 | Kaye Edward M. MD Director | Option exercise 10b5-1 | +25,000 | $0.60 | $15K | 74,124 |
| 2025-10-08 | Kaye Edward M. MD Director | Sale 10b5-1 | −25,000 | $30.00 | $750K | 49,124 |
| 2025-10-08 | Kaye Edward M. MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 542,801 | ||
| 2025-10-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise 10b5-1 | +10,000 | $9.15 | $92K | 21,831 |
| 2025-10-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −10,000 | $25.07 | $251K | 11,831 |
| 2025-10-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 34,800 | ||
| 2025-10-03 | Kaye Edward M. MD Director | Sale 10b5-1 | −42,461 | $25.09 | $1.1M | 49,124 |
| 2025-10-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −5,343 | $23.64 | $126K | 13,126 |
| 2025-09-30 | LEVIN ARTHUR A Director | Option exercise | +1,211 | 3,631 | ||
| 2025-09-30 | LEVIN ARTHUR A Director | Option exercise · Restricted Stock Units | −1,211 | 1,211 | ||
| 2025-09-04 | Kaye Edward M. MD Director | Returned to the company · Employee Stock Option (Right to Buy) | −178,500 | 37,500 | ||
| 2025-09-04 | Kaye Edward M. MD Director | Returned to the company · Restricted Stock Units | −144,000 | 0 | ||
| 2025-09-03 | Kaye Edward M. MD Director | Sale 10b5-1 | −45,996 | $20.13 | $926K | 91,585 |
| 2025-09-03 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −6,345 | $20.07 | $127K | 11,831 |
Page 9 of 13 · 256 trades